These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29674502)

  • 1. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
    Hrdinová J; D'Angelo S; Graça NAG; Ercig B; Vanhoorelbeke K; Veyradier A; Voorberg J; Coppo P
    Haematologica; 2018 Jul; 103(7):1099-1109. PubMed ID: 29674502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.
    Laghmouchi A; Graça NAG; Voorberg J
    Front Immunol; 2021; 12():757192. PubMed ID: 34858410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Miyadera H; Kubo M; Nakajima F; Matsumoto M
    J Thromb Haemost; 2023 Mar; 21(3):616-628. PubMed ID: 36696200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated thrombotic thrombocytopenic purpura and susceptible HLA alleles].
    Sakai K
    Rinsho Ketsueki; 2022; 63(4):277-285. PubMed ID: 35491217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
    Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
    J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric thrombotic thrombocytopenic purpura.
    Joly BS; Coppo P; Veyradier A
    Eur J Haematol; 2018 Oct; 101(4):425-434. PubMed ID: 29889319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
    Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13 Biomarkers in Management of Immune Thrombotic Thrombocytopenic Purpura.
    Sui J; Zheng L; Zheng XL
    Arch Pathol Lab Med; 2023 Aug; 147(8):974-979. PubMed ID: 36223210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpura.
    Cataland SR; Wu HM
    Semin Hematol; 2011 Oct; 48(4):242-50. PubMed ID: 22000089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Matsumoto M; De Waele L; Dekimpe C; Hamada E; Kubo M; Tersteeg C; De Meyer SF; Vanhoorelbeke K
    Blood Adv; 2023 Jan; 7(1):131-140. PubMed ID: 36306339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.
    Sakai K; Kuwana M; Tanaka H; Hosomichi K; Hasegawa A; Uyama H; Nishio K; Omae T; Hishizawa M; Matsui M; Iwato K; Okamoto A; Okuhiro K; Yamashita Y; Itoh M; Kumekawa H; Takezako N; Kawano N; Matsukawa T; Sano H; Ohshiro K; Hayashi K; Ueda Y; Mushino T; Ogawa Y; Yamada Y; Murata M; Matsumoto M
    Blood; 2020 Jun; 135(26):2413-2419. PubMed ID: 32253422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and management.
    Roose E; Veyradier A; Vanhoorelbeke K
    Curr Opin Hematol; 2020 Sep; 27(5):320-326. PubMed ID: 32740038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
    Sui J; Cao W; Halkidis K; Abdelgawwad MS; Kocher NK; Guillory B; Williams LA; Gangaraju R; Marques MB; Zheng XL
    Blood Adv; 2019 Dec; 3(24):4177-4186. PubMed ID: 31856267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatment.
    le Besnerais M; Veyradier A; Benhamou Y; Coppo P
    Expert Opin Biol Ther; 2019 Nov; 19(11):1127-1134. PubMed ID: 31359806
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
    Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
    Mazepa MA; Park YA; Raval JS
    Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endothelial dysfunction in thrombotic thrombocytopenic purpura: therapeutic perspectives].
    Prevel R; Roubaud-Baudron C; Tellier E; Le Besnerais M; Kaplanski G; Veyradier A; Benhamou Y; Coppo P;
    Rev Med Interne; 2021 Mar; 42(3):202-209. PubMed ID: 33455838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.